European Patent Office

T 0323/05 (Finasteride/MERCK) du 09.08.2007

Identifiant européen de la jurisprudence
ECLI:EP:BA:2007:T032305.20070809
Date de la décision
9 août 2007
Numéro de l'affaire
T 0323/05
Requête en révision de
-
Numéro de la demande
93203163.6
Classe de la CIB
C07J 73/00
Langue de la procédure
Anglais
Distribution
Distribuées aux présidents et aux membres des chambres de recours (B)
Téléchargement
Décision en anglais
Versions JO
Aucun lien JO trouvé
Autres décisions pour cet affaire
-
Résumés pour cette décision
-
Titre de la demande
A process for the production of finasteride
Nom du demandeur
Merck & Co., Inc.
Nom de l'opposant
Gedeon Richter Ltd.
Chambre
3.3.01
Sommaire
-
Mots-clés
Adaptation of the description after a decision to maintain the patent in amended form - consistent with the amended set of claims (yes)
Exergue
Rule 57a EPC establishes a limit to the amendments which can be made to the patent in suit, namely the amendments must be occasioned by grounds of opposition specified in Article 100 EPC, even if the respective ground has not been invoked by the opponent.
Article 84 and Rule 57a EPC are the two provisions which must guide the Proprietor of the patent when he is invited by the Opposition Division to adapt the description. In other words, the amendments must be appropriate and necessary, and nothing more (see point 3 of the reasons).

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the first instance with the order to maintain the patent on the basis of the claims as ordered by the Board in its decision of 16 September 2003, page 2 of the description as maintained by the decision of the Opposition Division dated 27 January 2005 and page 3 of the description as in the main request filed on 4 July 2007.